Dr Michael Täger
SET Asset Management GmbH
An assessment of the various options available to your organisation with regards to monetisation,
How can you further monetize your IP assets through licensing, cross-licensing etc.?
How can Ocean Tomo empower Life Science IP’s, and how does this best suit Pharmaceutical companies